Ivabradine to slow heart rate in sepsis ICU patients
Treatments studied
Part of Infections clinical trials.
This study tests whether ivabradine (a heart-rate medicine) can improve blood flow and other vital measurements in adults with sepsis in the ICU. It may help by lowering a fast heart rate when blood pressure is already being supported.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are an adult age 18 or older
- You are being treated in an intensive care unit (ICU)
- A doctor has diagnosed sepsis with infection plus a worsening SOFA score (Sepsis-3 rules)
- Your blood pressure is being supported so mean arterial pressure stays at least 65 mmHg for at least 2 hours on the same vasopressor doses
- Your heart rhythm is sinus rhythm, with heart rate 95 bpm or higher for at least 2 hours but under 72 hours
- You have NOT already taken ivabradine before this study
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how well the heart and blood vessels work together in people with sepsis or septic shock. It may help doctors understand heart function better during serious infections, which could lead to improved care.
This trial tests if the oral medication midodrine can help wean patients with sepsis off IV vasopressors faster, potentially reducing ICU stays and complications.
This study looks at how checking heart function with an ultrasound during early sepsis treatment can help guide fluid and medication decisions. It may lead to better recovery by tailoring treatment to each patient's heart.
This study looks at a special blood flow monitor (perfusion index) to see if it can help doctors decide when to give blood pressure raising medicines in patients with serious infections. It might help doctors better treat sepsis and septic shock.
This study tests whether gentle electrical stimulation through thin needles placed in the lower legs (electroacupuncture) can help patients fight sepsis in the ICU. It aims to see if this treatment reduces organ damage and speeds recovery.
This trial tests a medication called esmolol (a short-acting beta-blocker) to see if it can improve blood flow in tiny blood vessels (microcirculation) and help stabilize blood pressure in people with septic shock who have a fast heart rate. The goal is to see if slowing the heart rate can improve organ function and recovery.
Hear when a new Sepsis trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.